.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Novartis
Fish and Richardson
Healthtrust
Moodys
Merck
UBS
Daiichi Sankyo
AstraZeneca
Argus Health

Generated: July 23, 2017

DrugPatentWatch Database Preview

PROTAMINE ZINC AND ILETIN II Drug Profile

« Back to Dashboard

What is the patent landscape for Protamine Zinc And Iletin Ii, and what generic Protamine Zinc And Iletin Ii alternatives are available?

Protamine Zinc And Iletin Ii is a drug marketed by Lilly and is included in two NDAs.

The generic ingredient in PROTAMINE ZINC AND ILETIN II is insulin susp protamine zinc purified pork. There are thirty-eight drug master file entries for this compound. Additional details are available on the insulin susp protamine zinc purified pork profile page.

Summary for Tradename: PROTAMINE ZINC AND ILETIN II

Patents:0
Applicants:1
NDAs:2
Clinical Trials: see list105,123
Drug Prices:see details
DailyMed Link:PROTAMINE ZINC AND ILETIN II at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
PROTAMINE ZINC AND ILETIN II
insulin susp protamine zinc purified beef
INJECTABLE;INJECTION018476-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lilly
PROTAMINE ZINC AND ILETIN II (PORK)
insulin susp protamine zinc purified pork
INJECTABLE;INJECTION018346-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Teva
Novartis
Harvard Business School
Boehringer Ingelheim
Dow
Covington
Fish and Richardson
Mallinckrodt
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot